vcvibes

Foresite Capital

Foresite Capital VI-A, LLC

Late investment period

Late investment period: no first sale reported; age from Form D filed Dec 2021 (approximate)

Vintage
Unknown
Fund size
$17.21M to $20.12M (Form D and SEC adviser filing)
Stages
Pre-seed, Seed, Series A, Series B, Growth
Sectors
Biotech, Healthtech
Regions
Not stated

01 · Thesis

Foresite Capital is a multi-stage healthcare and life sciences investor. It backs companies that leverage biology and big data, focusing on the intersection of tech and biotech, from incubation through IPO.Inferred from the firm's website

02 · Initial check

$115K to $251K (estimated from fund size)

Estimated from Form D and SEC adviser filing

03 · Who to approach

Named on this fund's Form D

  • Jim Tananbaum, Founder & CEO

04 · Deals

No deals attributed to this fund yet.

05 · Evidence

  • Firm-wideForesite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages of their life cycles.

    Foresite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages of their life cycles.
    https://www.foresitecapital.com/

06 · Sources

  1. https://www.foresitecapital.com/
  2. https://www.sec.gov/Archives/edgar/data/1899120/000189912021000001/

Last verified: Oct 28, 2026